Summit Trail Advisors, LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1698478
NEW YORK, NY
Position in CRL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,950,537
+$93,592 QoQ
Shares Held
13,010
-21.4% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#169
of 564 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $40,569,660 across 16 Diagnostics & Research names. CRL ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,026 | $6,530,715 | |
| 2 | ILMN |
Illumina, Inc.
|
22,808 | $4,010,330 | |
| 3 | DHR |
Danaher Corp /De/
|
19,635 | $3,740,074 | |
| 4 | DGX |
Quest Diagnostics Inc
|
15,051 | $3,190,059 | |
| 5 | A |
Agilent Technologies, Inc.
|
23,182 | $3,079,265 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
This page
|
13,010 | $2,950,537 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,384 | $2,779,276 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
4,777 | $2,514,803 |
All Filings in CRL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,950,537 | 13,010 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,856,945 | 16,562 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,412,903 | 17,109 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,902,333 | 18,550 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,191,436 | 14,443 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||